Three of my positions are higher by 10%+ this morning, on news that “The Fly” is a superior being to all of you.
Our ‘modified risk’ cigarette play just got a little less risky.
Chardan Capital Markets raises their XXII tgt to $11.50 from $3.50. Firm’s tgt move is premised by the proximate cause of Big Tobacco’s decline, in their view, was the FDA’s announcement on July 28 to begin a “comprehensive regulatory plan to shift trajectory of tobacco-related disease, death,” beginning with a public dialogue about lowering nicotine levels in combustible cigarettes to non-addictive levels through achievable product standards. Assuming the FDA continues on its program, firm believes XXII has the opportunity to license its technology to Big Tobacco at a fraction of the cost they are currently contemplating it will take to comply with potential FDA regulations and this could result in a royalties or licensing stream far surpassing today’s market cap. While firm’s tgt is based on changes in the US market they expect other countries to follow the FDA’s lead, opening up additional markets for XXII and higher expected value for the shares.
I also have a very high IQ.
$HIIQ: Health Insurance Innovations sees Q3 EPS and revs above consensus; announces $50 mln share repurchase program (18.90)
Co issues upside guidance for Q3 (Sep), sees EPS of $0.44-0.46 vs. $0.35 Capital IQ Consensus Estimate; sees Q3 (Sep) revs of $62.3-63.3 mln vs. $54.98 mln Capital IQ Consensus Estimate.
Additionally, the Company expects to report EBITDA in the range of $9.4 million to $9.9 million and adjusted EBITDA of $12.3 million to $12.8 million for the same period. The expected range in GAAP net income represents an increase of approximately 8% to 18%, and the expected range in EBITDA represents an increase of approximately 27% to 34%, over the comparable prior year period.
Co also announced that its Board of Directors has authorized the repurchase of up to $50 million of the Company’s Class A common stock through October 2019.
Briefing Note: HIIQ provides less expensive plans on their online marketplaces. This company along with peer eHealth (EHTH) might benefit from President Trump’s executive order last week that will instruct the Federal agencies to allow consumers to purchase cheaper and less detailed healthcare plans. This order will also allow consumers to purchase healthcare across state lines.
And for the hat trick, shares of HMNY are higher by 11.5% this morning, without news, simply jogging on into the sunrise of optimism.If you enjoy the content at iBankCoin, please follow us on Twitter